Randomized double-blind placebo-controlled phase II/III trial in adjuvant NSCLC patients with the candidate cancer vaccine IGN101

被引:1
|
作者
Loibner, H.
Eckert, H.
Stoiber, W.
Groiss, F.
Stoelben, E.
机构
[1] HL Biosci Res, Vienna, Austria
[2] Altropus, Arlesheim, Switzerland
[3] Krankenhaus Merheim, Cologne, Germany
关键词
D O I
10.1200/jco.2008.26.15_suppl.3012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3012
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI®
    Vilaplana, C.
    Montane, E.
    Pinto, S.
    Barriocanal, A. M.
    Domenech, G.
    Torres, F.
    Cardona, P. J.
    Costa, Joan
    VACCINE, 2010, 28 (04) : 1106 - 1116
  • [32] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
    Miyazaki, Shougo
    Hagihara, Akihito
    Kanda, Ryo
    Mukaino, Yoshito
    Nobutomo, Koichi
    CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
  • [33] A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease
    Mizuno, Yoshikuni
    Hattori, Nobutaka
    Kondo, Tomoyoshi
    Nomoto, Masahiro
    Origasa, Hideki
    Takahashi, Ryosuke
    Yamamoto, Mitsutoshi
    Yanagisawa, Nobuo
    CLINICAL NEUROPHARMACOLOGY, 2017, 40 (05) : 201 - 207
  • [34] Phase III randomized, double-blind, placebo-controlled trial of donepezil in irradiated brain tumor survivors
    Rapp, Stephen R.
    Case, Doug
    Peiffer, Ann
    Naughton, Michelle Joy
    Stieber, Volker W.
    Bayer, Gerald K.
    Bilodeau, Paul A.
    Moore, Dennis Frederic
    Falchuk, Steven Charles
    Needles, Burton M.
    Piephoff, James
    Edenfield, William J.
    Giguere, Jeffrey K.
    Erickson, Nicholette
    Loghin, Monica Elena
    Shaw, Edward G.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Re: Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy - Response
    Vansteenkiste, JF
    Colowick, AB
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (10) : 762 - 763
  • [36] A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis
    Uchio, Yuji
    Enomoto, Hiroyuki
    Alev, Levent
    Kato, Yuki
    Ishihara, Hiroyuki
    Tsuji, Toshinaga
    Ochiai, Toshimitsu
    Konno, Shinichi
    JOURNAL OF PAIN RESEARCH, 2018, 11 : 809 - 821
  • [37] Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
    Inman, Robert D.
    Davis, John C., Jr.
    van der Heijde, Desiree
    Dickman, Laura
    Sieper, Joachim
    Kim, Sung Il
    Mack, Michael
    Han, John
    Visvanathan, Sudha
    Xu, Zhenhua
    Su, Benjamin
    Beutler, Anna
    Braun, Juergen
    ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3402 - 3412
  • [38] THE SAFETY AND TOLERABILITY OF LACOSAMIDE IN RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II/III CLINICAL TRIALS
    Gil-Nagel, A.
    Biton, V.
    Fountain, N.
    Rosenow, F.
    Hebert, D.
    Doty, P.
    EPILEPSIA, 2009, 50 : 110 - 110
  • [39] Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: A randomized, double-blind, placebo-controlled trial
    Umezawa, Yoshinori
    Nakagawa, Hidemi
    Tamaki, Kunihiko
    JOURNAL OF DERMATOLOGY, 2016, 43 (03): : 288 - 293
  • [40] A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
    Wen, Patrick Y.
    Reardon, David A.
    Armstrong, Terri S.
    Phuphanich, Surasak
    Aiken, Robert D.
    Landolfi, Joseph C.
    Curry, William T.
    Zhu, Jay-Jiguang
    Glantz, Michael
    Peereboom, David M.
    Markert, James M.
    LaRocca, Renato
    O'Rourke, Donald M.
    Fink, Karen
    Kim, Lyndon
    Gruber, Michael
    Lesser, Glenn J.
    Pan, Edward
    Kesari, Santosh
    Muzikansky, Alona
    Pinilla, Clemencia
    Santos, Radleigh G.
    Yu, John S.
    CLINICAL CANCER RESEARCH, 2019, 25 (19) : 5799 - 5807